Aimmune's IPO nets $149mm
Aimmune Therapeutics Inc. (food allergy desensitization therapies) netted $149mm through its initial public offering of 10mm shares at $16. (The company had hoped to sell 8.3mm shares between $14-16.) Existing investors agreed to purchase 1.56mm of the IPO shares.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com